![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 16, 2022 10:39:39 AM
https://twitter.com/alphavestcap/status/1537424207960854530
ae kusterer
Wednesday, June 15, 2022 10:04:03 PM
Re: None
Post#
487271
of 487327
NWBO possible pending announcements:
Could Sawston be approved for 1000 per month production before DC VAX L commercial approval?
Here is my current thought process:
* Marnix says they have been working on MHRA approval since January(see 5/11/22 Telegram comment by an attendee at the NYAS NYC Mulholland presentation)
* In January they were just about to publish but they rightly decided to incorporate the external controls group
* they don’t need a publication to apply for approval they only submit actual raw data
* the process takes 150 days plus time between the stages
* Advent has been hiring steadily. First production people this winter now hiring international patient coordinators.
* ramping up manual production to 100
* working up to 1000 per month with Flaskworks
* They we’re running test runs with Flaskworks last summer.
So I’m thinking that they will have UK approval august-September if they started in January. Or end of year if they started in May (unlikely)
https://smithonstocks.com/could-there-have-been-hundreds-of-millions-or-even-more-than-a-billion-counterfeit-shares-of-northwest-biotherapeutics-created-through-illegal-naked-shorting/( How many NWBO shares are sold short?)
https://www.bbc.com/news/health-61709542
Patients in England can get early access to more cutting-edge medicines through a new fund.
The Innovative Medicines Fund (IMF) works like the existing Cancer Drugs Fund (CDF), fast-tracking promising treatments, even if they are expensive and have not yet been approved for routine NHS use.
It will cover potentially life-saving drugs for rare and genetic diseases.
The government has allocated up to £680m a year to be shared by the funds.
The IMF, like the CDF, will mean a newly approved medicine could be prescribed immediately, before final recommendations on it are drawn up by the advisory body that weighs the cost versus benefit of drugs used by the NHS - an organisation called NICE (the National Institute for Health and Care Excellence).
Patients would be able to access the treatment while data is collected for NICE to determine whether the medicine is affordable and effective enough to offer more widely.
(5/31/22 UCLA presentation suggests Dr.Liau's combo trial with DC Vax L and Keytruda shows greater efficacy than Dc Vax L alone.)@alphavestcap $nwbo https://t.co/9CRp1bisev
— alphavestcapital.com (@alphavestcap) June 13, 2022
(Dr. Ashkan's trial data, Dr.Bosch's path to 1000 patient doses per month at Sawston)@litmpodcast ( agree? ) $nwbo @alphavestcap https://t.co/DYPeBXtSBp
— alphavestcapital.com (@alphavestcap) June 15, 2022
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169159859 (The path to commercial approval in the UK which is potentially a $2.5-5.0 business.)
Reefrad
Thursday, June 16, 2022 9:07:20 AM
Re: None
Post#
487328
of 487340
From DI this morning:
XXXX,
As you can imagine we are working on all fronts to get to the end goal of approval. We did articulate ( can be found on virtual trials.com) the production side of DCVax-L at ASCO 2022,which is a key component to the entire therapy. As we achieve milestones or have well defined clarity,like the production side mentioned above, on the many fronts we are actively engaged in, we will certainly announce them. Sorry I cannot be of more help.
Best
Dave
Turner5
Thursday, June 16, 2022 9:17:57 AM
Re: None
Post#
487335
of 487343
Peer review article comes out this weekend. Production capabilities increase 10 fold. UK approves for sales and their health insurance pays in July. What's your guess for market cap end of July?
I'm guessing 5 billion/ 4 per share
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM